+49 2066 50687-70

Noscendo GmbH given prestigious award as an “Employer Of The Future”

Aug 31, 2023 | news

We are incredibly excited to share with you that Noscendo GmbH has been given a prestigious award as an “Employer Of The Future” from the Deutsche Innovationsinstitut für Nachhaltigkeit und Digitalisierung – DIND (The German Innovation Institute for Sustainability and Digitization – DIND). This is in cooperation with Germany’s largest business magazine DUP UNTERNEHMER (German Entrepreneur Platform).

Christina Koumourzi-Ridil, our VP People, said “Our people are Noscendo’s most valuable asset and we are on a mission to keep attracting top talent that can help us succeed in revolutionising infection diagnostics and in turn helping to saving patient lives, with DISQVER.”

DISQVER simultaneously identifies more than 16,000 microbes in just one blood sample, including 1,500 described pathogenic bacteria, DNA viruses, fungi and parasites*. Next-generation sequencing (NGS) is used to sequence the cell-free DNA in the patient’s blood. DISQVER matches this information with Noscendo’s clinical genome database using bioinformatics algorithms. Within 24 hours of receipt of the sample in the laboratory, the analysis is available and provides precise results on all relevant pathogens found in the blood.

View open opportunities at Noscendo: www.noscendo.com/career/

To learn more about DIND: www.dind.info

To learn more about DUP magazine: www.dup-magazin.de/

*Scientific studies on DISQVER® can be found under Publications.

Information for physicians

More precise diagnostics – more knowledge: Find out more about the clinical use of DISQVER!

How DISQVER works

Information for medical disciplines



Read more about Noscendo and DISQVER or visit us at trade fairs and conferences!

All News





DISQVER together – get to know Noscendo!



Advisory Board